Senior Vice President Regulatory Affairs @ (October 2017 - March 2020)
Senior Vice President and Head of Global Regulatory Affairs @ (November 2012 - October 2017)
Vice President, Regulatory Affairs, Global Branded Products @ (October 2011 - November 2012)
Vice President, Worldwide Regulatory Affairs @ Cephalon (acquired by Teva) (June 2010 - October 2011)
Vice President - Consulting and Compliance @ (May 2005 - April 2010)
Regulatory Affairs @ (May 1981 - May 2005)
James Ottinger Education
Temple University
BS (Pharmacy)
1976-1981
James Ottinger Skills
21 CFR Part 11
AutoCAD
Biopharmaceuticals
Biotechnology
CRO
CTMS
Change Control
Clinical Development
Clinical Research
Clinical Trials
Drug Development
Drug Discovery
EMA
FDA
Financial Analysis
GCP
IND
Life Sciences
Medical Writing
Neurology
Neuroscience
Oncology
Pharmaceutical Industry
Pharmaceutics
Pharmacovigilance
Psychiatry
REMS
Regulations
Regulatory Affairs
Regulatory Requirements
Regulatory Submissions
Therapeutic Areas
U.S. Food and Drug Administration (FDA)
U.S. Title 21 CFR Part 11 Regulation
eCTD
Research
Change Management
Business Analysis
u.s. Food and Drug Administration Fda
Regulatory
u.s. Food and Drug Administration
James Ottinger Summary
James Ottinger, based in Philadelphia, PA, US, is currently a Executive Vice President, Regulatory and Quality at UroGen Pharma. James Ottinger brings experience from previous roles at UroGen Pharma, Teva Pharmaceuticals and Cephalon (acquired by Teva). James Ottinger holds a 1976 - 1981 BS in Pharmacy @ Temple University. With a robust skill set that includes 21 CFR Part 11, AutoCAD, Biopharmaceuticals, Biotechnology, CRO and more. James Ottinger has 4 emails and 4 mobile phone numbers on RocketReach.
Looking for a different James Ottinger?
Find contact details for 700 million professionals.